ArticleScientific reports2025
Cloning and expression of chromate reductase from Bacillus paramycoides S48 for chromium remediation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reduction of Hexavalent Chromium by Stenotrophomonas and Bacillus.MicrobiologyOpen · 2026Review
- Survival tactics ofFrontiers in microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study explores the production and characterization of chromium reductase from Bacillus paramycoides S48, focusing on its ability to effectively reduce toxic hexavalent chromium to less harmful chromium. The strain exhibited 65% reduction in Cr(VI) within 96 h at 30 °C. Clear morphological and functional group shifts on strain S48 cell surface treated with metal were noted using analytical tools i.e. SEM-EDX and FT-IR. The physico-chemical conditions such as temperature, pH and nutritional factors were optimized for better chromate reductase yield using Placket-Burman and Central Composite design software. The purified chromate reductase, obtained through size exclusion column chromatography, demonstrated a specific activity of 1416.5 U/mg, and 6.6-fold increase in purity, with a molecular mass of approximately 35 kDa. The enzyme exhibited stability at temperature 30-40 °C and pH 5.0-8.0. Furthermore, the purified chromium reductase achieved, 80% reduction of toxic Cr(VI) at temperature 35 °C after 96 h. The BparChR gene was successfully cloned into the pET-28a vector, expressed in E. coli BL21, and purified through Ni-Affinity ion exchange chromatography. The recombinant BparChR protein displayed a specific activity of 1680 U/mg, and a purification fold of 5.73 times. The BparChR exhibited a remarkable 90% reduction in chromium after 96 h, surpassing the efficacy of whole-cell and native chromium reductase. This study concludes that B. paramycoides S48, holds promise for the cost-effective and environmentally friendly detoxification of chromium in contaminated industrial effluents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.